Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Cardiovascular Risk FactorNicotine Dependence
Interventions
OTHER

Electronic Cigarette

E-cigarette Device: The delivery device will be a variable wattage all-in-one device with operating wattage of 7.0 - 75.0 W, which is inclusive of the three power levels we intend to study.

Trial Locations (2)

94110

Zuckerberg San Francisco General Hospital, San Francisco

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Food and Drug Administration (FDA)

FED

lead

University of California, San Francisco

OTHER

NCT03839745 - Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power | Biotech Hunter | Biotech Hunter